Chang, J. T. Pathophysiology of inflammatory bowel diseases. N. Engl. J. Med. 383, 2652–2664 (2020).
Article CAS PubMed Google Scholar
Baumgart, D. C. & Le Berre, C. Newer biologic and small-molecule therapies for inflammatory bowel disease. N. Engl. J. Med. 385, 1302–1315 (2021).
Article CAS PubMed Google Scholar
Roda, G., Jharap, B., Neeraj, N. & Colombel, J. F. Loss of response to anti-TNFs: definition, epidemiology, and management. Clin. Transl. Gastroenterol. 7, e135 (2016).
Article CAS PubMed PubMed Central Google Scholar
Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
Article CAS PubMed PubMed Central Google Scholar
Verstockt, B., Van Assche, G., Vermeire, S. & Ferrante, M. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Expert. Opin. Biol. Ther. 17, 31–47 (2017).
Article CAS PubMed Google Scholar
Kobayashi, M. et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827–845 (1989).
Article CAS PubMed Google Scholar
Hsieh, C. S. et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547–549 (1993).
Article CAS PubMed Google Scholar
Manetti, R. et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199–1204 (1993).
Article CAS PubMed Google Scholar
Seder, R. A., Gazzinelli, R., Sher, A. & Paul, W. E. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90, 10188–10192 (1993).
Article CAS PubMed PubMed Central Google Scholar
Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715–725 (2000).
Article CAS PubMed Google Scholar
Brombacher, F. et al. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11, 325–332 (1999).
Article CAS PubMed Google Scholar
Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003).
Article CAS PubMed Google Scholar
Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87–113 (2008).
Article CAS PubMed PubMed Central Google Scholar
Pirhonen, J., Matikainen, S. & Julkunen, I. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169, 5673–5678 (2002).
Article CAS PubMed Google Scholar
Verreck, F. A. et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl Acad. Sci. USA 101, 4560–4565 (2004).
Article CAS PubMed PubMed Central Google Scholar
Cella, M. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T–T help via APC activation. J. Exp. Med. 184, 747–752 (1996).
Article CAS PubMed Google Scholar
Wesa, A. & Galy, A. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol. 3, 14 (2002).
Article PubMed PubMed Central Google Scholar
Ma, X. et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183, 147–157 (1996).
Article CAS PubMed Google Scholar
Luque-Martin, R. et al. IFN-gamma drives human monocyte differentiation into highly proinflammatory macrophages that resemble a phenotype relevant to psoriasis. J. Immunol. 207, 555–568 (2021).
Article CAS PubMed Google Scholar
Shi, Q. et al. PGE2 elevates IL-23 production in human dendritic cells via a cAMP dependent pathway. Mediat. Inflamm. 2015, 984690 (2015).
Geyer, C. E. et al. C-reactive protein controls IL-23 production by human monocytes. Int. J. Mol. Sci. 22, 11638 (2021).
Article CAS PubMed PubMed Central Google Scholar
Lim, K. S. et al. Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells. J. Biol. Chem. 295, 6387–6400 (2020).
Article CAS PubMed PubMed Central Google Scholar
Macho-Fernandez, E. et al. Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells. Mucosal Immunol. 8, 403–413 (2015).
Article CAS PubMed Google Scholar
Moschen, A. R., Tilg, H. & Raine, T. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat. Rev. Gastroenterol. Hepatol. 16, 185–196 (2019).
Article CAS PubMed Google Scholar
Schwarz, E. & Carson, W. E. III Analysis of potential biomarkers of response to IL-12 therapy. J. Leukoc. Biol. 112, 557–567 (2022).
Article CAS PubMed Google Scholar
Grohmann, U. et al. Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J. Immunol. 167, 221–227 (2001).
Article CAS PubMed Google Scholar
Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699–5708 (2002).
Article CAS PubMed Google Scholar
Awasthi, A. et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904–5908 (2009).
Article CAS PubMed Google Scholar
Frucht, D. M. IL-23: a cytokine that acts on memory T cells. Sci. STKE 2002, pe1 (2002).
Ivanov, I. I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
Article CAS PubMed Google Scholar
Glassman, C. R. et al. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells. Cell 184, 983–999.e924 (2021).
Article CAS PubMed PubMed Central Google Scholar
Thierfelder, W. E. et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171–174 (1996).
Article CAS PubMed Google Scholar
Floss, D. M. et al. Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor. J. Biol. Chem. 288, 19386–19400 (2013).
Article CAS PubMed PubMed Central Google Scholar
Sun, R., Hedl, M. & Abraham, C. IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes. Gut 69, 264–273 (2020).
Article CAS PubMed Google Scholar
Becker, C. et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112, 693–706 (2003).
Article CAS PubMed PubMed Central Google Scholar
Fuss, I. J. et al. Both IL-12p70 and IL-23 are synthesized during active Crohn’s disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12, 9–15 (2006).
Kullberg, M. C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203, 2485–2494 (2006).
留言 (0)